Cargando…

Special Issue “Anticancer Drugs 2021”

Detalles Bibliográficos
Autores principales: Meegan, Mary J., O’Boyle, Niamh M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025550/
https://www.ncbi.nlm.nih.gov/pubmed/35455476
http://dx.doi.org/10.3390/ph15040479
_version_ 1784690900690010112
author Meegan, Mary J.
O’Boyle, Niamh M.
author_facet Meegan, Mary J.
O’Boyle, Niamh M.
author_sort Meegan, Mary J.
collection PubMed
description
format Online
Article
Text
id pubmed-9025550
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-90255502022-04-23 Special Issue “Anticancer Drugs 2021” Meegan, Mary J. O’Boyle, Niamh M. Pharmaceuticals (Basel) Editorial MDPI 2022-04-14 /pmc/articles/PMC9025550/ /pubmed/35455476 http://dx.doi.org/10.3390/ph15040479 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Editorial
Meegan, Mary J.
O’Boyle, Niamh M.
Special Issue “Anticancer Drugs 2021”
title Special Issue “Anticancer Drugs 2021”
title_full Special Issue “Anticancer Drugs 2021”
title_fullStr Special Issue “Anticancer Drugs 2021”
title_full_unstemmed Special Issue “Anticancer Drugs 2021”
title_short Special Issue “Anticancer Drugs 2021”
title_sort special issue “anticancer drugs 2021”
topic Editorial
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9025550/
https://www.ncbi.nlm.nih.gov/pubmed/35455476
http://dx.doi.org/10.3390/ph15040479
work_keys_str_mv AT meeganmaryj specialissueanticancerdrugs2021
AT oboyleniamhm specialissueanticancerdrugs2021